Enterprise Statistical Leadership
- Own and define the statistical strategy across all programs, ensuring alignment with clinical, regulatory, and corporate objectives
- Serve as the single point of accountability for all statistical methodologies, assumptions, and outputs used in decision-making
- Guide the organization on innovative statistical approaches for gene therapy and rare disease (small populations, adaptive designs, etc.)
- Influence development strategy through data-driven insights and risk framing
Department Leadership & Capability Build
- Establish and lead the Biostatistics function as a standalone capability, including operating model, standards, and talent strategy
- Define how Biostatistics interfaces with Data Management, Programming, Clinical, and Regulatory
- Build a scalable, fit-for-purpose model leveraging internal leadership and external partners
- Set clear expectations for accountability, quality, and delivery across all biometrics activities
Regulatory & Submission Leadership (Elevated)
- Serve as the lead statistical voice in regulatory interactions, including FDA/EMA meetings and submission strategy
- Ensure all statistical components of INDs, BLAs, and regulatory responses are defensible, consistent, and inspection-ready
- Own the statistical narrative in submissions (not just outputs), including interpretation and positioning of results
- Anticipate and proactively address regulatory risk related to data and analysis
Program-Level Accountability
- Accountable for statistical design and execution across all trials, including:
- Study design and endpoints
- Sample size and power considerations
- Interim analysis and decision frameworks
- Ensure delivery of:
- SAPs
- TLFs
- CDISC-compliant datasets
- Integrated summaries
- Act as a core member of program leadership, not a downstream function
Operational Excellence
- Drive performance of CROs and vendors with clear ownership of outcomes, not oversight alone
- Ensure biometrics execution aligns to milestone-driven timelines (IND, BLA, topline data)
- Implement processes that balance:
- Speed (lean biotech reality)
- Rigor (regulatory expectations)
- Ensure continuous inspection readiness
Cross-Functional Leadership
- Partner with:
- Clinical Development (study design & execution)
- Regulatory (submission strategy & HA interactions)
- Program Leadership (timelines, risks, dependencies)
- Translate complex statistical outputs into clear, executive-level insights
- Contribute to board-level and investor-facing narratives where data interpretation is critical